United Orthopedic Corporation
Research United Orthopedic Corporation (4129.TWO) on Bullrun: market cap TWD 7.45B, P/E 14.1, dividend yield 6.2%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker4129.TWO
- ExchangeTWO
- CountryTaiwan
- SectorHealthcare
- IndustryMedical Devices
- CurrencyTWD
- Market capTWD 7.45B
- P/E14.1
- Dividend yield6.2%
- Financial periodQ2 2026
- RevenueTWD 1.57B
- Net incomeTWD 138.75M
- Free cash flow-TWD 133.90M
- Gross margin78.5%
Valuation Snapshot
latest market cap is TWD 7.45B; P/E is 14.1; dividend yield is 6.2%.
Peer valuation comparison
Latest P/E is 14.06x versus a Healthcare sector median of 21.8x (35.5% below).
Latest dividend yield is 6.19% versus a Healthcare sector median of 2.4% (157.9% above).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | TWD 7.45B | 14.1 | 5.8% | 4.5 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 4.5 TWD, yield 6.2%.
About United Orthopedic Corporation
United Orthopedic Corporation engages in the research, development, manufacture, and sale of orthopedic implants and surgical equipment in Taiwan, rest of Asia, America, Europe, Africa, and Oceania. The company offers artificial hip joints, partial hip joints, joints for large trochanteric fractures, Moore hip prostheses, and customized artificial hip joints for individual tumor patients;
ETFs that hold United Orthopedic Corporation
US-listed ETFs
United Orthopedic Corporation is held by 13 US-listed ETFs, going by the latest portfolios they filed with the SEC. The 8 most traded of them:
| ETF | Weight | Fee |
|---|---|---|
| Avantis Emerging Markets Equity ETF (AVEM) | <0.01% | 0.33% |
| State Street SPDR Portfolio Emerging Markets ETF (SPEM) | <0.01% | 0.07% |
| Dimensional Emerging Core Equity Market ETF (DFAE) | <0.01% | 0.29% |
| Dimensional Emerging Markets Core Equity 2 ETF (DFEM) | <0.01% | 0.39% |
| Dimensional World ex U.S. Core Equity 2 ETF (DFAX) | <0.01% | 0.28% |
| Dimensional Emerging Markets Value ETF (DFEV) | <0.01% | 0.43% |
| Avantis Emerging Markets Value ETF (AVES) | 0.01% | 0.36% |
| Avantis Emerging Markets Ex-China Equity ETF (AVXC) | <0.01% | 0.33% |
Portfolios as filed with the SEC on Form N-PORT, dated May to July 2026. Brokers in the EU generally do not offer US-listed ETFs to retail investors.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is United Orthopedic Corporation's market cap?
United Orthopedic Corporation's market capitalization is TWD 7.45B.
What is United Orthopedic Corporation's P/E ratio?
United Orthopedic Corporation's price-to-earnings (P/E) ratio is 14.1.
Does United Orthopedic Corporation pay a dividend?
United Orthopedic Corporation has a dividend yield of 6.2%.
What does United Orthopedic Corporation do?
United Orthopedic Corporation engages in the research, development, manufacture, and sale of orthopedic implants and surgical equipment in Taiwan, rest of Asia, America, Europe, Africa, and Oceania.